SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-042218
Filing Date
2020-09-01
Accepted
2020-09-01 17:11:31
Documents
5
Period of Report
2020-10-16
Effectiveness Date
2020-09-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A srne-def14a_20201016.htm DEF 14A 1927916
2 GRAPHIC gew02cvzybw3000001.jpg GRAPHIC 4411
3 GRAPHIC gew02cvzybw3000004.jpg GRAPHIC 76875
4 GRAPHIC gew02cvzybw3000003.jpg GRAPHIC 66704
5 GRAPHIC gew02cvzybw3000002.jpg GRAPHIC 5611
  Complete submission text file 0001564590-20-042218.txt   2141161
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36150 | Film No.: 201155050
SIC: 2836 Biological Products, (No Diagnostic Substances)